Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-30

Clinical Trial Update: Menorrhagia Study in Women With Treatment-resistant Menorrhagia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Bayer investigating treatment for treatment-resistant menorrhagia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bayer | Conditions: Menorrhagia | Phase 2 | Status: COMPLETED